Search

Search bills, members, committees and pages...

Sign In

DAVID MARIN

PreviousNext

15 federal lobbying filings, 2023 to 2026.

DAVID MARIN is a registered lobbyist named on 15 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

2 they have filed under, by filings.

RegistrantFilingsReported
VIATRIS INC.12—
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION3—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20263—$6.6M
20254—$2.3M
20244—$2.6M
20234—$2.8M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues15
CPTCopyright/Patent/Trademark12
FINFinancial Institutions/Investments/Securities12
TRDTrade (domestic/foreign)12
BUDBudget/Appropriations5
DEFDefense5
MMMMedicare/Medicaid3
PHAPharmacy3
TAXTaxation/Internal Revenue Code1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1843To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.4
H.R. 9747Welcome Back to the Health Care Workforce Act4
S. 1302Increasing Transparency in Generic Drug Applications Act4
S. 891Bipartisan Health Care Act4
H.R. 1244Reducing Drug Prices for Seniors Act3
H.R. 2214DRUG Act3
H.R. 3164Ensuring Community Access to Pharmacist Services Act3
H.R. 4132Prescription Information Modernization Act of 20253
H.R. 4317PBM Reform Act of 20253
H.R. 4409Fair Pharmacies for Federal Employees Act of 20253
H.R. 4570Interagency Patent Coordination and Improvement Act of 20253
H.R. 5582Patients Deserve Price Tags Act3
H.R. 6609Pharmacists Fight Back in Medicare and Medicaid Act3
H.R. 6610Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]3
H.R. 6837To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are con…3
H.R. 7148Consolidated Appropriations Act, 20263
H.R. 7871MVP Act3
H.R. 7895PBM Kickback Prohibition Act3
H.R. 8143Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.3
S. 1041Affordable Prescriptions for Patients Act3
S. 1095Stop STALLING Act3
S. 1096Preserve Access to Affordable Generics and Biosimilars Act3
S. 1097Interagency Patent Coordination and Improvement Act of 20253
S. 1414Expedited Access to Biosimilars Act3
S. 1637MVP Act3

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONPHARMACEUTICAL CARE MANAGEMENT ASSOCIATION2026 second_quarter$3.3MJul 20, 2026
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONPHARMACEUTICAL CARE MANAGEMENT ASSOCIATION2026 first_quarter$3MApr 21, 2026
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONPHARMACEUTICAL CARE MANAGEMENT ASSOCIATION2026 first_quarter$299.7KApr 20, 2026
VIATRIS INCVIATRIS INC.2025 fourth_quarter$490KJan 21, 2026
VIATRIS INCVIATRIS INC.2025 third_quarter$640KOct 20, 2025
VIATRIS INCVIATRIS INC.2025 second_quarter$590KJul 22, 2025
VIATRIS INCVIATRIS INC.2025 first_quarter$590KApr 22, 2025
VIATRIS INCVIATRIS INC.2024 fourth_quarter$510KJan 21, 2025
VIATRIS INCVIATRIS INC.2024 third_quarter$640KOct 21, 2024
VIATRIS INCVIATRIS INC.2024 second_quarter$770KJul 22, 2024
VIATRIS INCVIATRIS INC.2024 first_quarter$630KApr 22, 2024
VIATRIS INCVIATRIS INC.2023 fourth_quarter$620KJan 22, 2024
VIATRIS INCVIATRIS INC.2023 third_quarter$720KOct 20, 2023
VIATRIS INCVIATRIS INC.2023 second_quarter$780KJul 20, 2023
VIATRIS INCVIATRIS INC.2023 first_quarter$690KApr 20, 2023